MXCT vs WST · rev $38.6M vs P/E 35, rev $2.89B
MaxCyte Inc (MXCT) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported WST revenue for 2024-12-31 was $2.89B. Net income was $492.7M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. WST currently screens at market cap $15.97B and trailing P/E 34.8.
MXCT currently screens at market cap $124.3M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the MXCT and WST stock pages for the full models.
Not investment advice.